In what ways could the emergence of a cancer‑derived therapy for multiple sclerosis reshape pharmaceutical R&D investment models and regulatory pathways?

What are the potential geopolitical and technological spillover effects of Ukraine’s anti‑drone innovations on security architectures across the Middle East?

How might the United States’ demonstrated economic resilience during the Iran‑related conflict reshape global supply‑chain diversification strategies for multinational corporations?